Patients benefiting from federally qualified health centers tend to be sicker than the general population, but there are also disparities by state, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Patients benefiting from federally qualified health centers tend to be sicker than the general population, but there are also disparities by state, explained M. Kristina Wharton, MPH, of the Department of Global Health Management and Policy at Tulane University School of Public Health and Tropical Medicine.
Transcript
How does the health of the population using federally qualified health centers differ from the general population?
Sicker, mostly because of the designated medically underserved requirement of the health centers because they are in areas where people haven’t had access to care or are marginalized by their situation in public housing or they are homeless or they are a migrant farm worker or just somebody who doesn’t have health insurance and probably hasn’t had health insurance their whole life so they are on the whole a sicker population and have other greater socioeconomic and social determinant factors going into their healthcare besides their access to insurance which is also very important. This needs to be considered as it straps health centers with a lot of burden and responsibility, and I think plays a very important role in our country’s health care system.
Have you found disparities across the country in the patients being served by federally qualified health centers?
Certainly, in different states, it looks very different. In certain states, especially North Carolina, there is a large migrant farm population. In Southern California, that would be the same. So, even in the same state these health centers might vary a lot depending on what the patients need and what sort of programs they are running. In terms of access, we compare Medicaid expansion states and non-Medicaid expansion states and did various tests to see how health centers were different in different resource settings. And they are and their budgets are different and there’s a bigger proportion of HRSA programs in states that more resourced and have greater access to care and some of those states that have more health centers for people who don’t have health insurance.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More